Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: 0.3% OPA-15406 ointment;   Drug: 1% OPA-15406 ointment Sponsor:   Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials